CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW


TWO TECHNOLOGIES

ONE OBJECTIVE


To convert cancer and other degenerative diseases into non-lethal manageable conditions


Dr Graham Kelly, Executive Chairman

CLICK HERE TO READ THE LATEST CORPORATE OVERVIEW

CLICK HERE TO READ THE LATEST CORPORATE OVERVIEW

CLICK HERE TO READ THE BBY ANALYST REPORT

CLICK HERE TO READ THE BBY ANALYST REPORT

 

RESOURCES

All the Latest News >         STOP PRESS

BBY Analyst Report HERE

Latest Corporate Overview HERE

Message From the CEO HERE

Novogen Identifies Lead ATM Drug Candidate  HERE

CEO Report on AGM and the Future HERE

Cantrixil Highly Effective In Ovarian Test HERE

 

 

CONTACT DETAILS

 

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group

Graham.Kelly@novogen.com
+(61 2) 9472 4100

 

Media Enquiries
Cristyn Humphreys
Operations Manager Novogen Group

Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111 / + 61 499 088 482